GSK · GSK plc · Investor Relations
Market Cap
$98.62B
Shares
2.00B
Volume · Oct 2
5.39M
Avg daily vol (3M)
3.68M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-28 00:00 UTC | We will announce our third quarter results on Wednesday, 28 October 2026. | Results publication |
| 2027-02-03 00:00 UTC | We will announce our full year and fourth quarter results on Wednesday, 3 February 2027. | Results publication |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-23 | Julie Brown, Chief Financial Officer, will attended and take part in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 23 September 2026. | Conference |
| 2026-09-23 | Julie Brown, Chief Financial Officer, will attend and take part in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 23 September 2026. | Conference |
| 2026-09-15 | Hesham Abdullah, SVP, Global Oncology R&D, will participate at the Morgan Stanley’s 24th Annual Global Healthcare Conference in New York on Tuesday, 15 September 2026. | Conference |
| 2026-09-09 | Julie Brown, Chief Financial Officer, will attended and take part in a fireside chat at the Bernstein’s 23rd Annual Pan-European Strategic Decisions Conference in London on Wednesday, 9 September 2026. | Conference |
| 2026-07-28 | Q2 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
| 2026-04-29 | Q1 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
Source: https://www.gsk.com/en-gb/company/governance/shareholders/
Key facts
CIK
1131399
CUSIP
37733W204
13F (30d)
32 filings
22 filers
Visit website
Investor relations